Arthritis or bone and joint pain in children
BioMG follows French guidelines. Adapt it to the guidelines and the tests available where you practise.
Severity sign: refer as an emergency
- No tests in the community: paediatric emergency department the same day.
- Very painful, febrile monoarthritis (septic arthritis); fever with rash or impaired general condition. Associated cytopenia or bone pain (haematological malignancy): specialist opinion without delay.
Arthritis (swelling, limp, stiffness) without severity signs
Laboratory tests
- FBC with blood film
- CRP
- Antinuclear antibodies (arthritis for 6 weeks or more)if neededChronic arthritis (6 weeks or more): ANA identify the JIA at risk of chronic anterior uveitis, especially before age 6; they are positive in 75% of oligoarthritis [1,3].
- Serum creatinineif neededSuspected JIA: tests of the PNDS diagnostic work-up [1].
- ASTif neededSuspected JIA: tests of the PNDS diagnostic work-up [1].
- ALTif neededSuspected JIA: tests of the PNDS diagnostic work-up [1].
- LDH (if cytopenia, bone pain or impaired general condition)if neededA marked rise in LDH should raise the possibility of malignancy; a moderate rise is possible in systemic JIA [1].
- Rheumatoid factorif neededArthritis in a child over 6, especially polyarticular: identification of juvenile rheumatoid arthritis (rheumatoid factor-positive form) [1,3]. Rheumatoid factor is counted as positive (ILAR classification) only if positive on at least 2 occasions, at least 3 months apart, during the first 6 months of the disease [6].
- Anti-CCP antibodiesif neededArthritis in a child over 6, especially polyarticular: identification of juvenile rheumatoid arthritis (rheumatoid factor-positive form) [1,3]. Rheumatoid factor is counted as positive (ILAR classification) only if positive on at least 2 occasions, at least 3 months apart, during the first 6 months of the disease [6].
- Lyme serology (if tick bite in an endemic area)if neededMonoarthritis or oligoarthritis after a tick bite in a borreliosis-endemic area [1,3]. Without exposure or examination findings, Lyme serology is not requested [7].
- PTif needednon-French guidelineHaemarthrosis (haemorrhagic effusion) or suspected haemophilia: an American Family Physician review then considers a coagulation screen indicated, the aPTT being prolonged in haemophilia (expert opinion, 2015) [5].
- aPTTif needednon-French guidelineHaemarthrosis (haemorrhagic effusion) or suspected haemophilia: an American Family Physician review then considers a coagulation screen indicated, the aPTT being prolonged in haemophilia (expert opinion, 2015) [5].
Urine tests
- Urine dipstick (proteinuria, haematuria)
Other test
- If JIA suspected or ANA positive in a child under 6 years: prompt slit-lamp eye examination.
Do not order
- HLA-B27 as first-line: to be discussed with the expert centre; it can neither confirm nor exclude JIA with enthesitis (present in 70% of patients but also in 6 to 10% of the Caucasian population) [1].
- ESR: no longer in the fee schedule [8].
- Glycosylated ferritin: of no value outside a research protocol for the diagnosis of Still's disease (neither sensitive nor specific) [1].
- HLA-B27 outside a clinical suspicion of juvenile spondyloarthropathy (arthritis with enthesitis, inflammatory low back and buttock pain, sacroiliitis, acute anterior uveitis, family history): low screening value, 5 to 10% of healthy North Americans being carriers [7].
- Lyme serology for musculoskeletal symptoms without exposure (endemic area, tick bite) or examination findings: risk of false positives and unnecessary treatment [7].
Limb pain typical of "growing pains"
- No laboratory or imaging test if the picture is typical.
Do not order
- Antinuclear antibodies “to screen for” rheumatic disease in limb pain: a very poorly specific test (often positive at low titre in healthy children), with no value to confirm or exclude JIA; reserve for the question of lupus [4].
- Rheumatoid factor, anti-CCP for pain without arthritis or in a child under 6: the PNDS proposes them only after age 6, in the work-up of arthritis [1].
- Laboratory tests or imaging (X-rays, scintigraphy) for typical growing pains [2].
- Antinuclear antibodies as screening without specific signs of rheumatic disease: up to 20% of healthy people are positive; in JIA, positive ANA signal a risk of uveitis but are not used to make the diagnosis (Canadian Choosing Wisely recommendation) [7].
- Rheumatoid factor or anti-CCP in a child with arthralgia but no arthritis on examination (effusion, or at least 2 signs among warmth, tenderness, pain on forced movement, limitation) [7].
Sources (10)
- Centre de référence RAISE, filière FAI²R. Protocole national de diagnostic et de soins (PNDS) : Arthrites juvéniles idiopathiques. Décembre 2023, mis en ligne par la HAS le 7 février 2024 (non validé par la HAS) ; et sa synthèse à destination du médecin traitant.
- Uziel Y, Hashkes PJ. Growing pains in children. Pediatr Rheumatol Online J. 2007;5:5.
- Filière FAI²R, Filières de santé maladies rares. Les clés du diagnostic : Arthrite de l'enfant (Deslandre C, Cherqaoui B, Felten R, Richez C ; rédaction décembre 2022, mise en ligne juillet 2025).
- McGhee JL, Kickingbird LM, Jarvis JN. Clinical utility of antinuclear antibody tests in children. BMC Pediatr. 2004;4:13.
- Naranje S, Kelly DM, Sawyer JR. A Systematic Approach to the Evaluation of a Limping Child. Am Fam Physician. 2015;92(10):908-918.
- Petty RE, Southwood TR, Manners P, et al. International League of Associations for Rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001. J Rheumatol. 2004;31(2):390-392.
- Lim L, McMillan T, Chédeville G, et al. Choosing Wisely: The Canadian Rheumatology Association Pediatric Committee's list of items physicians and patients should question. J Rheumatol. 2023;50(12):1610-1618.
- Assurance maladie. Nomenclature des actes de biologie médicale (NABM), version 105 : absence d'acte pour la VS ; actes 1453 (AAN), 1452 (FR), 1827 (anti-CCP).
- National Institute for Health and Care Excellence. Lyme disease. NICE guideline NG95, publiée le 11 avril 2018, mise à jour le 17 octobre 2018 (recommandations 1.1 et 1.2).
- Angeles-Han ST, Ringold S, et al. 2019 American College of Rheumatology/Arthritis Foundation Guideline for the Screening, Monitoring, and Treatment of Juvenile Idiopathic Arthritis-Associated Uveitis. Arthritis Care Res (Hoboken). 2019;71:703-716.